Table 3.

Anti-inflammatory capabilities of ELEO.

		Changes in Paw Diameter Experimental Animals (Mean ± SEM)
Tested Sample	Dosage	1 h	2 h	3 h	Aver. Paw Diameter	% Inhibition
Carrageenan	1 mL	1.18 ± 0.06	1.46 ± 0.02	1.81 ± 0.02	1.48 ± 0.01	---
Normal saline	1 mL	1.15 ± 0.05	1.43 ± 0.02	1.77 ± 0.05	1.45 ± 0.03	---
Diclofenac sodium	50 mg/kg	0.47 ± 0.03	0.41 ± 0.04	0.30 ± 0.02	0.39 ± 0.06	73.64
EO	25	0.75 ± 0.04	0.66 ± 0.03	0.59 ± 0.04	0.66 ± 0.02 *	55.40
	50	0.71 ± 0.02	0.62 ± 0.04	0.51 ± 0.03	0.61 ± 0.05 *	58.78
	100	0.57 ± 0.05	0.51 ± 0.03	0.45 ± 0.05	0.51 ± 0.04 *	65.54

Carrageenan inducer of paw edema, normal saline as a negative control, and diclofenac sodium was used as a standard, EO essential oil with p ≤ 0.05 *.